Biofeedback assisted relaxation seems to have a positive effect in patients with type 2 diabetes, leading to significant decreases in blood sugar levels – controlling diabetes, the findings of a small study suggest.
Episodes of dangerously low blood glucose, or hypoglycemia, were greatly reduced in people who received an islet transplant for poorly controlled type 1 diabetes, according to an analysis of outcomes in 138 patients who had the procedure at 19 medical centers in the United States and Canada. This is one of the conclusions of the Collaborative Islet Transplant Registry (CITR), which tracks many factors affecting the success of this experimental procedure in people with severe type 1 diabetes.
Dr. Mikael Nilsson, of Lund University, Sweden, and team, studied the effect of whey protein on diabetic subjects consuming high glycemic index (GI) meals, which cause blood sugar levels to spike.
Several lines of recent scientific evidence have shown that individuals that followed a low GI diet over many years were at a significantly lower risk for developing both type 2 diabetes and coronary heart disease.
Glossodynia or burning mouth syndrome (BMS) is a condition characterized by a burning or tingling sensation on the lips, tongue, or entire mouth.
Inhaled insulin is effective therapy for patients with type 2 diabetes who fail to obtain adequate blood sugar control with diet and exercise, according to a report in the journal Diabetes Care.
Waist circumference is associated with insulin resistance in children and may offer a simple way to identify children with risk factors for cardiovascular disease and type 2 diabetes, according to a study in the August issue of the Archives of Pediatrics & Adolescent Medicine, one of the JAMA/Archives journals.
A drug that curbs appetite has been found to reduce a host of factors that contribute to type 2 diabetes – including elevated blood sugar levels, a study has shown.
Diabetic retinopathy has been found in nearly 8 percent of pre-diabetic participants in the Diabetes Prevention Program (DPP), according to a report presented today at the American Diabetes Association’s 65th Annual Scientific Sessions. Diabetic retinopathy, which can lead to vision loss, was also seen in 12 percent of participants with type 2 diabetes who developed diabetes during the DPP. No other long-term study has evaluated retinopathy in a population so carefully examined for the presence or development of type 2 diabetes.
A significantly lower risk of heart disease can now be added to the list of proven long-term benefits of tight glucose control in people with type 1 diabetes. Researchers announced this finding today at the annual scientific meeting of the American Diabetes Association after analyzing cardiovascular (CVD) events such as heart attack, stroke, and angina in patients who took part in the Diabetes Control and Complications Trial (DCCT) years ago.